Drug development Archives

News and Trends 25 Aug 2022

Evotec SE acquires highly-flexible drug manufacturing space for €1

A clinical and commercial manufacturing platform for small molecule therapeutics has expanded following an acquisition signed for. Evotec SE made the announcement today (August 25) after signing the contract yesterday for €1 to take Central Glass Germany GmbH from Japanese manufacturing company Central Glass Co. Ltd. It will now operate as Evotec Drug Substance (Germany) […]

August 25, 2022 - 2 minutesmins - By Liza Laws

researchers in lab; biotech collaboration

News and Trends 14 Jul 2022

GenScript ProBio enters strategic partnerships with two South Korean biotechs

GenScript ProBio, the CDMO segment of the leading biotech GenScript, has entered into a strategic partnership memorandum of understanding (MOU) with DAAN Bio Therapeutics for the discovery and development of novel drugs and with ACT Therapeutics to develop new CAR-T cell therapies. With offices located in the U.S., the Netherlands, China, Singapore and Japan, GenScript […]

July 14, 2022 - 3 minutesmins - By Omnia Ibrahim

organoids in a dish, drug development, patient relevant model

The organoid era: bringing patient-relevant preclinical models to the lab

Drug development is a lengthy and costly process that takes at least 10 years on average from drug discovery to commercialization, requiring billions of dollars in investment. However, over 90% of new drugs that are tested in clinical trials fail. Organoids — three-dimensional, patient-derived mini-organs in a dish — offer a solution to this challenge. […]

July 12, 2022 - 7 minutesmins - By Sudha Sundaram

Merck, drug development, lab work, lab worker, scientist

Top Reasons to Outsource Your Early Clinical Pipeline to a CDMO

Biotech firms partner with contract development and manufacturing organizations (CDMOs) to leverage their expertise in process development, optimization, and scale-up. In this article, we share an exclusive sneak-peek into a recent survey, which explores the main reasons why biotech companies collaborate with CDMOs at different stages of drug development. To make a new drug candidate […]

January 26, 2022 - 8 minutesmins - By Sudha Sundaram

Opinion 31 Aug 2021

Cloud Foundations for R&D: Designing the Future of Life Sciences

In recent years, artificial intelligence has been hailed as the next big thing in drug discovery. But to leverage the full potential of this technology the life sciences industry first needs to pay attention to experimental design and data collection. We embrace the latest digital technologies to enhance almost everything in our daily lives—from how […]

August 31, 2021 - 7 minutesmins - By External Contributor

In Depth 7 Jun 2021

The Post-Covid Future of AI for Drug Development

With the global Covid-19 outbreak in early 2020, pharma companies and biotechs have increasingly turned to artificial intelligence to improve precision and speed in drug development. Artificial intelligence (AI), the ability of machines to learn from new input, is a broad term for a range of computing methods. Recommendation engines used by online shopping or […]

June 7, 2021 - 11 minutesmins - By Matthew Williams

Opinion 19 Apr 2021

The Hidden Costs of Mismanaged R&D Projects in Biotech and Pharma

Mismanagement of R&D projects in biotech and pharma is more common than one might think and can result in high development costs and eventual clinical failure. Can we do something about it? Biotechnology and pharmaceutical businesses are synonymous with both a high risk and an even bigger investment. Bringing new drugs to the market can […]

April 19, 2021 - 7 minutesmins - By Auste Kanapeckaite

In Depth 22 Jul 2020

Artificial Intelligence: A Superpower in the Fight Against Covid-19

The rapid spread of Covid-19 around the world has left drug developers with limited time to identify drug candidates to fight the virus. Amid this crisis, artificial intelligence has proven its value as a tool to make drug discovery faster and cost-effective. Drug discovery is an expensive, long-winded process. Taking a drug from discovery to […]

July 22, 2020 - 8 minutesmins - By David Kirk

Why Biotechs Should Invest in Good Outsourcing Management of CROs

The relationship between biotechs and their CRO partners has been long in the making. These days, a collaboration with CROs is seen as a standard in the drug development industry. However, the management of drug development partners and providers can be highly challenging for biotechs. This is where outsourcing expertise can make the difference between […]

June 8, 2020 - 8 minutesmins - By External Contributor

How to Address the Challenges of Biologics Discovery and Development

The biologics industry is growing at an incredible rate. While its global market value was estimated at $236B in 2017, it is expected to rise to $310B by 2023. As key market players enter the field, competition is increasing. In recent years, the biologics industry has become more versatile and has moved from being primarily […]

November 27, 2019 - 6 minutesmins - By External Contributor

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Drug development

Evotec SE acquires highly-flexible drug manufacturing space for €1

GenScript ProBio enters strategic partnerships with two South Korean biotechs

The organoid era: bringing patient-relevant preclinical models to the lab

Top Reasons to Outsource Your Early Clinical Pipeline to a CDMO

Cloud Foundations for R&D: Designing the Future of Life Sciences

The Post-Covid Future of AI for Drug Development

The Hidden Costs of Mismanaged R&D Projects in Biotech and Pharma

Artificial Intelligence: A Superpower in the Fight Against Covid-19

Why Biotechs Should Invest in Good Outsourcing Management of CROs

How to Address the Challenges of Biologics Discovery and Development

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!